• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

JAK2 突变阳性的真性红细胞增多症伴 IgA 血管炎和肾病综合征:一例报告。

JAK2 mutation-positive polycythaemia vera associated with IgA vasculitis and nephrotic syndrome: a case report.

机构信息

Department of Rheumatology, Osaki Citizen Hospital, Osaki, Japan.

Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan.

出版信息

Mod Rheumatol Case Rep. 2020 Jul;4(2):289-295. doi: 10.1080/24725625.2020.1728061. Epub 2020 Feb 13.

DOI:10.1080/24725625.2020.1728061
PMID:33087019
Abstract

We report a case of polycythaemia vera (PV) associated with IgA vasculitis. A 45-year-old man was admitted for evaluation of abdominal pain and palpable purpura. IgA vasculitis was diagnosed, and oral prednisolone therapy (30 mg/day) was initiated. On day 6, the patient developed left hemiparesis, and magnetic resonance imaging revealed acute cerebral infarction. Bone marrow biopsy results and the identification of a Janus kinase 2 () mutation led to the diagnosis of PV. Despite steroid therapy, urine protein levels increased to 15 g/g・Cre. Renal biopsy demonstrated mild mesangial proliferation with IgA deposits, but immunosuppressive therapy was partially effective. This case suggests that PV can be a complication of IgA vasculitis and that preventive measures for thrombosis should be taken in such cases.

摘要

我们报告一例与 IgA 血管炎相关的真性红细胞增多症 (PV)。一名 45 岁男性因腹痛和可触及性紫癜入院。诊断为 IgA 血管炎,并开始口服泼尼松龙治疗(30mg/天)。第 6 天,患者出现左侧偏瘫,磁共振成像显示急性脑梗死。骨髓活检结果和 Janus 激酶 2 () 突变的鉴定导致 PV 的诊断。尽管进行了类固醇治疗,尿蛋白水平仍增加至 15g/g・Cre。肾活检显示轻度系膜增殖伴 IgA 沉积,但免疫抑制治疗部分有效。本病例提示 PV 可作为 IgA 血管炎的并发症,此类情况下应采取预防血栓形成的措施。

相似文献

1
JAK2 mutation-positive polycythaemia vera associated with IgA vasculitis and nephrotic syndrome: a case report.JAK2 突变阳性的真性红细胞增多症伴 IgA 血管炎和肾病综合征:一例报告。
Mod Rheumatol Case Rep. 2020 Jul;4(2):289-295. doi: 10.1080/24725625.2020.1728061. Epub 2020 Feb 13.
2
Low-dose corticosteroid with mizoribine might be an effective therapy for elderly-onset ISKDC grade VI IgA vasculitis.低剂量皮质类固醇联合吗替麦考酚酯可能是老年起病的 ISKDC 分级 VI 型 IgA 血管炎的有效治疗方法。
CEN Case Rep. 2021 Feb;10(1):46-52. doi: 10.1007/s13730-020-00513-6. Epub 2020 Aug 4.
3
Apparent 'JAK2-negative' polycythaemia vera due to compound mutations in exon 14.由于第14外显子的复合突变导致的表观“JAK2阴性”真性红细胞增多症。
Br J Haematol. 2017 Jul;178(2):333-336. doi: 10.1111/bjh.14126. Epub 2016 May 2.
4
[From gene to disease; JAK2 and polycythaemia vera].
Ned Tijdschr Geneeskd. 2007 Aug 11;151(32):1784-7.
5
Bone marrow morphologic features in polycythemia vera with JAK2 exon 12 mutations.骨髓形态学特征在伴有 JAK2 外显子 12 突变的真性红细胞增多症中。
Am J Clin Pathol. 2010 Jun;133(6):942-8. doi: 10.1309/AJCP3Z2AKUWRGTNM.
6
Difficulty distinguishing essential thrombocythaemia from polycythaemia vera in children with JAK2 V617F-positive myeloproliferative neoplasms.在携带JAK2 V617F阳性骨髓增殖性肿瘤的儿童中,区分原发性血小板增多症与真性红细胞增多症存在困难。
Br J Haematol. 2019 Apr;185(1):136-139. doi: 10.1111/bjh.15386. Epub 2018 May 16.
7
Ruxolitinib treatment in an infant with JAK2+ polycythaemia vera-associated Budd-Chiari syndrome.鲁索替尼治疗一名患有JAK2阳性真性红细胞增多症相关布加综合征的婴儿。
BMJ Case Rep. 2017 Jul 14;2017:bcr-2017-220377. doi: 10.1136/bcr-2017-220377.
8
An increase in diagnostic JAK2 V617F mutation testing: Is masked polycythaemia vera the explanantion?诊断性JAK2 V617F突变检测的增加:隐匿性真性红细胞增多症是原因吗?
Eur J Intern Med. 2018 Jun;52:e37-e38. doi: 10.1016/j.ejim.2018.03.017. Epub 2018 Apr 3.
9
Ischemic stroke as an initial performance of polycythemia vera in young adults: A case report and literature review.青年成人首发表现为血栓性血小板减少性紫癜性脑梗死 1 例报告并文献复习
Medicine (Baltimore). 2024 Feb 16;103(7):e36953. doi: 10.1097/MD.0000000000036953.
10
Open-label study of oral CEP-701 (lestaurtinib) in patients with polycythaemia vera or essential thrombocythaemia with JAK2-V617F mutation.CEP-701( lestaurtinib)口服治疗 JAK2-V617F 突变的真性红细胞增多症或原发性血小板增多症患者的开放性研究。
Br J Haematol. 2014 Jan;164(1):83-93. doi: 10.1111/bjh.12607. Epub 2013 Oct 28.